nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—malignant glioma	0.71	1	CbGaD
Ofloxacin—CYP1A2—Carmustine—malignant glioma	0.0869	1	CbGbCtD
Ofloxacin—Moxifloxacin—TOP2A—malignant glioma	0.00164	0.209	CrCbGaD
Ofloxacin—Interstitial lung disease—Carmustine—malignant glioma	0.00126	0.00749	CcSEcCtD
Ofloxacin—Interstitial lung disease—Temozolomide—malignant glioma	0.00122	0.00724	CcSEcCtD
Ofloxacin—Influenza-like symptoms—Temozolomide—malignant glioma	0.00121	0.00718	CcSEcCtD
Ofloxacin—Pefloxacin—TOP2A—malignant glioma	0.0012	0.153	CrCbGaD
Ofloxacin—Stupor—Carmustine—malignant glioma	0.0012	0.0071	CcSEcCtD
Ofloxacin—Scotoma—Carmustine—malignant glioma	0.00118	0.00699	CcSEcCtD
Ofloxacin—Menorrhagia—Temozolomide—malignant glioma	0.00117	0.00693	CcSEcCtD
Ofloxacin—Hepatotoxicity—Carmustine—malignant glioma	0.00116	0.00687	CcSEcCtD
Ofloxacin—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00115	0.00681	CcSEcCtD
Ofloxacin—Scotoma—Temozolomide—malignant glioma	0.00114	0.00675	CcSEcCtD
Ofloxacin—Enoxacin—TOP2A—malignant glioma	0.00112	0.143	CrCbGaD
Ofloxacin—Hepatotoxicity—Temozolomide—malignant glioma	0.00112	0.00664	CcSEcCtD
Ofloxacin—Coagulopathy—Temozolomide—malignant glioma	0.00111	0.00658	CcSEcCtD
Ofloxacin—Otitis media—Temozolomide—malignant glioma	0.00111	0.00658	CcSEcCtD
Ofloxacin—Hyperaesthesia—Temozolomide—malignant glioma	0.0011	0.00653	CcSEcCtD
Ofloxacin—Injection site pain—Carmustine—malignant glioma	0.00109	0.0065	CcSEcCtD
Ofloxacin—Rigors—Temozolomide—malignant glioma	0.00106	0.00628	CcSEcCtD
Ofloxacin—Petechiae—Temozolomide—malignant glioma	0.00105	0.00623	CcSEcCtD
Ofloxacin—Speech disorder—Carmustine—malignant glioma	0.00104	0.00617	CcSEcCtD
Ofloxacin—Sparfloxacin—TOP2A—malignant glioma	0.00103	0.131	CrCbGaD
Ofloxacin—Speech disorder—Temozolomide—malignant glioma	0.001	0.00596	CcSEcCtD
Ofloxacin—Drug interaction—Carmustine—malignant glioma	0.000963	0.00572	CcSEcCtD
Ofloxacin—Viral infection—Temozolomide—malignant glioma	0.000956	0.00568	CcSEcCtD
Ofloxacin—Leukocytosis—Carmustine—malignant glioma	0.000951	0.00564	CcSEcCtD
Ofloxacin—Herpes simplex—Temozolomide—malignant glioma	0.000937	0.00556	CcSEcCtD
Ofloxacin—Gait disturbance—Carmustine—malignant glioma	0.000915	0.00543	CcSEcCtD
Ofloxacin—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000913	0.00542	CcSEcCtD
Ofloxacin—Coordination abnormal—Carmustine—malignant glioma	0.00091	0.0054	CcSEcCtD
Ofloxacin—Hearing impaired—Temozolomide—malignant glioma	0.000907	0.00539	CcSEcCtD
Ofloxacin—Pulmonary embolism—Carmustine—malignant glioma	0.000893	0.0053	CcSEcCtD
Ofloxacin—Injection site reaction—Carmustine—malignant glioma	0.000888	0.00527	CcSEcCtD
Ofloxacin—Gait disturbance—Temozolomide—malignant glioma	0.000885	0.00525	CcSEcCtD
Ofloxacin—Respiratory failure—Temozolomide—malignant glioma	0.000879	0.00522	CcSEcCtD
Ofloxacin—Coordination abnormal—Temozolomide—malignant glioma	0.000879	0.00522	CcSEcCtD
Ofloxacin—Vaginal inflammation—Temozolomide—malignant glioma	0.000863	0.00513	CcSEcCtD
Ofloxacin—Pulmonary embolism—Temozolomide—malignant glioma	0.000863	0.00513	CcSEcCtD
Ofloxacin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000863	0.00513	CcSEcCtD
Ofloxacin—Urinary incontinence—Carmustine—malignant glioma	0.000863	0.00512	CcSEcCtD
Ofloxacin—Depressed level of consciousness—Carmustine—malignant glioma	0.000863	0.00512	CcSEcCtD
Ofloxacin—Skin exfoliation—Carmustine—malignant glioma	0.000853	0.00506	CcSEcCtD
Ofloxacin—Candida infection—Carmustine—malignant glioma	0.000853	0.00506	CcSEcCtD
Ofloxacin—Lomefloxacin—TOP2A—malignant glioma	0.00085	0.108	CrCbGaD
Ofloxacin—Neuropathy—Carmustine—malignant glioma	0.000839	0.00498	CcSEcCtD
Ofloxacin—Influenza like illness—Temozolomide—malignant glioma	0.000838	0.00498	CcSEcCtD
Ofloxacin—Depressed level of consciousness—Temozolomide—malignant glioma	0.000834	0.00495	CcSEcCtD
Ofloxacin—Urinary incontinence—Temozolomide—malignant glioma	0.000834	0.00495	CcSEcCtD
Ofloxacin—Candida infection—Temozolomide—malignant glioma	0.000824	0.00489	CcSEcCtD
Ofloxacin—Skin exfoliation—Temozolomide—malignant glioma	0.000824	0.00489	CcSEcCtD
Ofloxacin—Vaginal infection—Temozolomide—malignant glioma	0.000815	0.00484	CcSEcCtD
Ofloxacin—Neuropathy—Temozolomide—malignant glioma	0.000811	0.00481	CcSEcCtD
Ofloxacin—Aplastic anaemia—Temozolomide—malignant glioma	0.000811	0.00481	CcSEcCtD
Ofloxacin—Neoplasm—Carmustine—malignant glioma	0.000808	0.0048	CcSEcCtD
Ofloxacin—Dry eye—Temozolomide—malignant glioma	0.000797	0.00473	CcSEcCtD
Ofloxacin—Neoplasm—Temozolomide—malignant glioma	0.000781	0.00463	CcSEcCtD
Ofloxacin—Abnormal vision—Carmustine—malignant glioma	0.000779	0.00463	CcSEcCtD
Ofloxacin—Sepsis—Carmustine—malignant glioma	0.000775	0.0046	CcSEcCtD
Ofloxacin—Abnormal vision—Temozolomide—malignant glioma	0.000753	0.00447	CcSEcCtD
Ofloxacin—Phlebitis—Carmustine—malignant glioma	0.000753	0.00447	CcSEcCtD
Ofloxacin—Thrombophlebitis—Carmustine—malignant glioma	0.000749	0.00445	CcSEcCtD
Ofloxacin—Diabetes mellitus—Carmustine—malignant glioma	0.000746	0.00443	CcSEcCtD
Ofloxacin—Swelling—Carmustine—malignant glioma	0.000735	0.00436	CcSEcCtD
Ofloxacin—Ear pain—Temozolomide—malignant glioma	0.000735	0.00436	CcSEcCtD
Ofloxacin—Levofloxacin—TOP2A—malignant glioma	0.000727	0.0924	CrCbGaD
Ofloxacin—Thrombophlebitis—Temozolomide—malignant glioma	0.000724	0.0043	CcSEcCtD
Ofloxacin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000721	0.00428	CcSEcCtD
Ofloxacin—Eye pain—Carmustine—malignant glioma	0.000718	0.00427	CcSEcCtD
Ofloxacin—Gastroenteritis—Temozolomide—malignant glioma	0.000707	0.0042	CcSEcCtD
Ofloxacin—Ciprofloxacin—TOP2A—malignant glioma	0.000702	0.0893	CrCbGaD
Ofloxacin—Deafness—Temozolomide—malignant glioma	0.000701	0.00416	CcSEcCtD
Ofloxacin—Vascular purpura—Temozolomide—malignant glioma	0.000701	0.00416	CcSEcCtD
Ofloxacin—Hepatic failure—Temozolomide—malignant glioma	0.000697	0.00414	CcSEcCtD
Ofloxacin—Eye pain—Temozolomide—malignant glioma	0.000694	0.00412	CcSEcCtD
Ofloxacin—Amnesia—Carmustine—malignant glioma	0.00069	0.0041	CcSEcCtD
Ofloxacin—Hot flush—Temozolomide—malignant glioma	0.00067	0.00398	CcSEcCtD
Ofloxacin—Amnesia—Temozolomide—malignant glioma	0.000667	0.00396	CcSEcCtD
Ofloxacin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000664	0.00394	CcSEcCtD
Ofloxacin—Menopausal symptoms—Temozolomide—malignant glioma	0.000664	0.00394	CcSEcCtD
Ofloxacin—Thirst—Temozolomide—malignant glioma	0.000659	0.00391	CcSEcCtD
Ofloxacin—Hyponatraemia—Carmustine—malignant glioma	0.000651	0.00387	CcSEcCtD
Ofloxacin—Purpura—Temozolomide—malignant glioma	0.00065	0.00386	CcSEcCtD
Ofloxacin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000649	0.00385	CcSEcCtD
Ofloxacin—Diplopia—Carmustine—malignant glioma	0.000649	0.00385	CcSEcCtD
Ofloxacin—Diplopia—Temozolomide—malignant glioma	0.000627	0.00372	CcSEcCtD
Ofloxacin—Face oedema—Carmustine—malignant glioma	0.000626	0.00372	CcSEcCtD
Ofloxacin—Affect lability—Temozolomide—malignant glioma	0.000617	0.00366	CcSEcCtD
Ofloxacin—Ataxia—Carmustine—malignant glioma	0.00061	0.00362	CcSEcCtD
Ofloxacin—Face oedema—Temozolomide—malignant glioma	0.000605	0.00359	CcSEcCtD
Ofloxacin—Mood swings—Temozolomide—malignant glioma	0.000594	0.00353	CcSEcCtD
Ofloxacin—Hypokalaemia—Carmustine—malignant glioma	0.00059	0.0035	CcSEcCtD
Ofloxacin—Norfloxacin—TOP2A—malignant glioma	0.000589	0.0749	CrCbGaD
Ofloxacin—Ataxia—Temozolomide—malignant glioma	0.000589	0.0035	CcSEcCtD
Ofloxacin—Dehydration—Temozolomide—malignant glioma	0.000583	0.00346	CcSEcCtD
Ofloxacin—Dry skin—Temozolomide—malignant glioma	0.000574	0.00341	CcSEcCtD
Ofloxacin—Hypokalaemia—Temozolomide—malignant glioma	0.00057	0.00339	CcSEcCtD
Ofloxacin—Breast disorder—Temozolomide—malignant glioma	0.000566	0.00336	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000564	0.00335	CcSEcCtD
Ofloxacin—Dysphagia—Carmustine—malignant glioma	0.000561	0.00333	CcSEcCtD
Ofloxacin—Abdominal distension—Temozolomide—malignant glioma	0.000545	0.00324	CcSEcCtD
Ofloxacin—Dysphagia—Temozolomide—malignant glioma	0.000542	0.00322	CcSEcCtD
Ofloxacin—Pancytopenia—Carmustine—malignant glioma	0.000532	0.00316	CcSEcCtD
Ofloxacin—Sweating increased—Temozolomide—malignant glioma	0.000528	0.00313	CcSEcCtD
Ofloxacin—Neutropenia—Carmustine—malignant glioma	0.000524	0.00311	CcSEcCtD
Ofloxacin—Bronchitis—Temozolomide—malignant glioma	0.000521	0.00309	CcSEcCtD
Ofloxacin—Pancytopenia—Temozolomide—malignant glioma	0.000514	0.00305	CcSEcCtD
Ofloxacin—Neutropenia—Temozolomide—malignant glioma	0.000507	0.00301	CcSEcCtD
Ofloxacin—Dysuria—Temozolomide—malignant glioma	0.000507	0.00301	CcSEcCtD
Ofloxacin—Hyperglycaemia—Carmustine—malignant glioma	0.000506	0.003	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000503	0.00299	CcSEcCtD
Ofloxacin—Pneumonia—Carmustine—malignant glioma	0.000503	0.00298	CcSEcCtD
Ofloxacin—Pollakiuria—Temozolomide—malignant glioma	0.0005	0.00297	CcSEcCtD
Ofloxacin—Erectile dysfunction—Temozolomide—malignant glioma	0.000499	0.00296	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000494	0.00294	CcSEcCtD
Ofloxacin—Renal failure—Carmustine—malignant glioma	0.000491	0.00292	CcSEcCtD
Ofloxacin—Weight decreased—Temozolomide—malignant glioma	0.00049	0.00291	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Carmustine—malignant glioma	0.00049	0.00291	CcSEcCtD
Ofloxacin—Hyperglycaemia—Temozolomide—malignant glioma	0.000489	0.0029	CcSEcCtD
Ofloxacin—Stomatitis—Carmustine—malignant glioma	0.000487	0.00289	CcSEcCtD
Ofloxacin—Pneumonia—Temozolomide—malignant glioma	0.000486	0.00288	CcSEcCtD
Ofloxacin—Infestation NOS—Temozolomide—malignant glioma	0.000483	0.00287	CcSEcCtD
Ofloxacin—Infestation—Temozolomide—malignant glioma	0.000483	0.00287	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000479	0.00284	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000473	0.00281	CcSEcCtD
Ofloxacin—Stomatitis—Temozolomide—malignant glioma	0.000471	0.0028	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Temozolomide—malignant glioma	0.000457	0.00271	CcSEcCtD
Ofloxacin—Sinusitis—Temozolomide—malignant glioma	0.000453	0.00269	CcSEcCtD
Ofloxacin—Haemoglobin—Carmustine—malignant glioma	0.000451	0.00268	CcSEcCtD
Ofloxacin—Haemorrhage—Carmustine—malignant glioma	0.000449	0.00266	CcSEcCtD
Ofloxacin—Hypoaesthesia—Carmustine—malignant glioma	0.000446	0.00265	CcSEcCtD
Ofloxacin—Hallucination—Carmustine—malignant glioma	0.000446	0.00265	CcSEcCtD
Ofloxacin—Oedema peripheral—Carmustine—malignant glioma	0.000442	0.00262	CcSEcCtD
Ofloxacin—Connective tissue disorder—Carmustine—malignant glioma	0.000441	0.00262	CcSEcCtD
Ofloxacin—Haemoglobin—Temozolomide—malignant glioma	0.000436	0.00259	CcSEcCtD
Ofloxacin—Haemorrhage—Temozolomide—malignant glioma	0.000434	0.00257	CcSEcCtD
Ofloxacin—Hepatitis—Temozolomide—malignant glioma	0.000434	0.00257	CcSEcCtD
Ofloxacin—Visual impairment—Carmustine—malignant glioma	0.000432	0.00257	CcSEcCtD
Ofloxacin—Hallucination—Temozolomide—malignant glioma	0.000431	0.00256	CcSEcCtD
Ofloxacin—Hypoaesthesia—Temozolomide—malignant glioma	0.000431	0.00256	CcSEcCtD
Ofloxacin—Pharyngitis—Temozolomide—malignant glioma	0.00043	0.00255	CcSEcCtD
Ofloxacin—Urinary tract disorder—Temozolomide—malignant glioma	0.000428	0.00254	CcSEcCtD
Ofloxacin—Oedema peripheral—Temozolomide—malignant glioma	0.000427	0.00254	CcSEcCtD
Ofloxacin—Connective tissue disorder—Temozolomide—malignant glioma	0.000426	0.00253	CcSEcCtD
Ofloxacin—Urethral disorder—Temozolomide—malignant glioma	0.000425	0.00252	CcSEcCtD
Ofloxacin—Eye disorder—Carmustine—malignant glioma	0.000419	0.00249	CcSEcCtD
Ofloxacin—Visual impairment—Temozolomide—malignant glioma	0.000418	0.00248	CcSEcCtD
Ofloxacin—Flushing—Carmustine—malignant glioma	0.000416	0.00247	CcSEcCtD
Ofloxacin—Erythema multiforme—Temozolomide—malignant glioma	0.00041	0.00243	CcSEcCtD
Ofloxacin—Eye disorder—Temozolomide—malignant glioma	0.000405	0.00241	CcSEcCtD
Ofloxacin—Tinnitus—Temozolomide—malignant glioma	0.000404	0.0024	CcSEcCtD
Ofloxacin—Flushing—Temozolomide—malignant glioma	0.000402	0.00239	CcSEcCtD
Ofloxacin—Cardiac disorder—Temozolomide—malignant glioma	0.000402	0.00239	CcSEcCtD
Ofloxacin—Arrhythmia—Carmustine—malignant glioma	0.000401	0.00238	CcSEcCtD
Ofloxacin—Alopecia—Carmustine—malignant glioma	0.000396	0.00235	CcSEcCtD
Ofloxacin—Angiopathy—Temozolomide—malignant glioma	0.000393	0.00234	CcSEcCtD
Ofloxacin—Mental disorder—Carmustine—malignant glioma	0.000393	0.00233	CcSEcCtD
Ofloxacin—Immune system disorder—Temozolomide—malignant glioma	0.000392	0.00233	CcSEcCtD
Ofloxacin—Mediastinal disorder—Temozolomide—malignant glioma	0.000391	0.00232	CcSEcCtD
Ofloxacin—Malnutrition—Carmustine—malignant glioma	0.000391	0.00232	CcSEcCtD
Ofloxacin—Erythema—Carmustine—malignant glioma	0.000391	0.00232	CcSEcCtD
Ofloxacin—Chills—Temozolomide—malignant glioma	0.000389	0.00231	CcSEcCtD
Ofloxacin—Alopecia—Temozolomide—malignant glioma	0.000383	0.00227	CcSEcCtD
Ofloxacin—Mental disorder—Temozolomide—malignant glioma	0.00038	0.00226	CcSEcCtD
Ofloxacin—Back pain—Carmustine—malignant glioma	0.000378	0.00224	CcSEcCtD
Ofloxacin—Malnutrition—Temozolomide—malignant glioma	0.000377	0.00224	CcSEcCtD
Ofloxacin—Erythema—Temozolomide—malignant glioma	0.000377	0.00224	CcSEcCtD
Ofloxacin—Dysgeusia—Temozolomide—malignant glioma	0.00037	0.00219	CcSEcCtD
Ofloxacin—Vision blurred—Carmustine—malignant glioma	0.000368	0.00219	CcSEcCtD
Ofloxacin—Tremor—Carmustine—malignant glioma	0.000366	0.00217	CcSEcCtD
Ofloxacin—Back pain—Temozolomide—malignant glioma	0.000365	0.00217	CcSEcCtD
Ofloxacin—Anaemia—Carmustine—malignant glioma	0.000361	0.00214	CcSEcCtD
Ofloxacin—Agitation—Carmustine—malignant glioma	0.000359	0.00213	CcSEcCtD
Ofloxacin—Vision blurred—Temozolomide—malignant glioma	0.000356	0.00211	CcSEcCtD
Ofloxacin—Tremor—Temozolomide—malignant glioma	0.000354	0.0021	CcSEcCtD
Ofloxacin—Ill-defined disorder—Temozolomide—malignant glioma	0.00035	0.00208	CcSEcCtD
Ofloxacin—Leukopenia—Carmustine—malignant glioma	0.00035	0.00208	CcSEcCtD
Ofloxacin—Anaemia—Temozolomide—malignant glioma	0.000349	0.00207	CcSEcCtD
Ofloxacin—Agitation—Temozolomide—malignant glioma	0.000347	0.00206	CcSEcCtD
Ofloxacin—Angioedema—Temozolomide—malignant glioma	0.000345	0.00205	CcSEcCtD
Ofloxacin—Malaise—Temozolomide—malignant glioma	0.00034	0.00202	CcSEcCtD
Ofloxacin—Vertigo—Temozolomide—malignant glioma	0.000339	0.00201	CcSEcCtD
Ofloxacin—Leukopenia—Temozolomide—malignant glioma	0.000338	0.00201	CcSEcCtD
Ofloxacin—Hypertension—Carmustine—malignant glioma	0.000337	0.002	CcSEcCtD
Ofloxacin—Palpitations—Temozolomide—malignant glioma	0.000334	0.00198	CcSEcCtD
Ofloxacin—Chest pain—Carmustine—malignant glioma	0.000332	0.00197	CcSEcCtD
Ofloxacin—Myalgia—Carmustine—malignant glioma	0.000332	0.00197	CcSEcCtD
Ofloxacin—Anxiety—Carmustine—malignant glioma	0.000331	0.00197	CcSEcCtD
Ofloxacin—Cough—Temozolomide—malignant glioma	0.000329	0.00196	CcSEcCtD
Ofloxacin—Hypertension—Temozolomide—malignant glioma	0.000326	0.00193	CcSEcCtD
Ofloxacin—Confusional state—Carmustine—malignant glioma	0.000321	0.00191	CcSEcCtD
Ofloxacin—Myalgia—Temozolomide—malignant glioma	0.000321	0.00191	CcSEcCtD
Ofloxacin—Arthralgia—Temozolomide—malignant glioma	0.000321	0.00191	CcSEcCtD
Ofloxacin—Anxiety—Temozolomide—malignant glioma	0.00032	0.0019	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000319	0.00189	CcSEcCtD
Ofloxacin—Oedema—Carmustine—malignant glioma	0.000319	0.00189	CcSEcCtD
Ofloxacin—Discomfort—Temozolomide—malignant glioma	0.000317	0.00188	CcSEcCtD
Ofloxacin—Infection—Carmustine—malignant glioma	0.000317	0.00188	CcSEcCtD
Ofloxacin—Dry mouth—Temozolomide—malignant glioma	0.000314	0.00187	CcSEcCtD
Ofloxacin—Thrombocytopenia—Carmustine—malignant glioma	0.000312	0.00185	CcSEcCtD
Ofloxacin—Tachycardia—Carmustine—malignant glioma	0.000311	0.00185	CcSEcCtD
Ofloxacin—Confusional state—Temozolomide—malignant glioma	0.000311	0.00184	CcSEcCtD
Ofloxacin—Anaphylactic shock—Temozolomide—malignant glioma	0.000308	0.00183	CcSEcCtD
Ofloxacin—Oedema—Temozolomide—malignant glioma	0.000308	0.00183	CcSEcCtD
Ofloxacin—Infection—Temozolomide—malignant glioma	0.000306	0.00182	CcSEcCtD
Ofloxacin—Anorexia—Carmustine—malignant glioma	0.000304	0.0018	CcSEcCtD
Ofloxacin—Nervous system disorder—Temozolomide—malignant glioma	0.000302	0.00179	CcSEcCtD
Ofloxacin—Thrombocytopenia—Temozolomide—malignant glioma	0.000302	0.00179	CcSEcCtD
Ofloxacin—Skin disorder—Temozolomide—malignant glioma	0.000299	0.00178	CcSEcCtD
Ofloxacin—Hypotension—Carmustine—malignant glioma	0.000298	0.00177	CcSEcCtD
Ofloxacin—Hyperhidrosis—Temozolomide—malignant glioma	0.000298	0.00177	CcSEcCtD
Ofloxacin—Anorexia—Temozolomide—malignant glioma	0.000294	0.00174	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00029	0.00172	CcSEcCtD
Ofloxacin—Insomnia—Carmustine—malignant glioma	0.000288	0.00171	CcSEcCtD
Ofloxacin—Paraesthesia—Carmustine—malignant glioma	0.000286	0.0017	CcSEcCtD
Ofloxacin—Dyspnoea—Carmustine—malignant glioma	0.000284	0.00169	CcSEcCtD
Ofloxacin—Somnolence—Carmustine—malignant glioma	0.000283	0.00168	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000281	0.00167	CcSEcCtD
Ofloxacin—Insomnia—Temozolomide—malignant glioma	0.000279	0.00165	CcSEcCtD
Ofloxacin—Decreased appetite—Carmustine—malignant glioma	0.000277	0.00165	CcSEcCtD
Ofloxacin—Paraesthesia—Temozolomide—malignant glioma	0.000277	0.00164	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000275	0.00163	CcSEcCtD
Ofloxacin—Dyspnoea—Temozolomide—malignant glioma	0.000275	0.00163	CcSEcCtD
Ofloxacin—Somnolence—Temozolomide—malignant glioma	0.000274	0.00163	CcSEcCtD
Ofloxacin—Constipation—Carmustine—malignant glioma	0.000273	0.00162	CcSEcCtD
Ofloxacin—Pain—Carmustine—malignant glioma	0.000273	0.00162	CcSEcCtD
Ofloxacin—Dyspepsia—Temozolomide—malignant glioma	0.000271	0.00161	CcSEcCtD
Ofloxacin—Decreased appetite—Temozolomide—malignant glioma	0.000268	0.00159	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000266	0.00158	CcSEcCtD
Ofloxacin—Fatigue—Temozolomide—malignant glioma	0.000266	0.00158	CcSEcCtD
Ofloxacin—Pain—Temozolomide—malignant glioma	0.000263	0.00156	CcSEcCtD
Ofloxacin—Constipation—Temozolomide—malignant glioma	0.000263	0.00156	CcSEcCtD
Ofloxacin—Feeling abnormal—Carmustine—malignant glioma	0.000263	0.00156	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Carmustine—malignant glioma	0.000261	0.00155	CcSEcCtD
Ofloxacin—Feeling abnormal—Temozolomide—malignant glioma	0.000254	0.00151	CcSEcCtD
Ofloxacin—Abdominal pain—Carmustine—malignant glioma	0.000252	0.0015	CcSEcCtD
Ofloxacin—Body temperature increased—Carmustine—malignant glioma	0.000252	0.0015	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000252	0.0015	CcSEcCtD
Ofloxacin—Urticaria—Temozolomide—malignant glioma	0.000245	0.00145	CcSEcCtD
Ofloxacin—Body temperature increased—Temozolomide—malignant glioma	0.000243	0.00145	CcSEcCtD
Ofloxacin—Abdominal pain—Temozolomide—malignant glioma	0.000243	0.00145	CcSEcCtD
Ofloxacin—Hypersensitivity—Carmustine—malignant glioma	0.000235	0.00139	CcSEcCtD
Ofloxacin—Asthenia—Carmustine—malignant glioma	0.000229	0.00136	CcSEcCtD
Ofloxacin—Hypersensitivity—Temozolomide—malignant glioma	0.000227	0.00135	CcSEcCtD
Ofloxacin—Asthenia—Temozolomide—malignant glioma	0.000221	0.00131	CcSEcCtD
Ofloxacin—Diarrhoea—Carmustine—malignant glioma	0.000218	0.00129	CcSEcCtD
Ofloxacin—Pruritus—Temozolomide—malignant glioma	0.000218	0.00129	CcSEcCtD
Ofloxacin—Dizziness—Carmustine—malignant glioma	0.000211	0.00125	CcSEcCtD
Ofloxacin—Diarrhoea—Temozolomide—malignant glioma	0.000211	0.00125	CcSEcCtD
Ofloxacin—Dizziness—Temozolomide—malignant glioma	0.000204	0.00121	CcSEcCtD
Ofloxacin—Vomiting—Carmustine—malignant glioma	0.000203	0.0012	CcSEcCtD
Ofloxacin—Rash—Carmustine—malignant glioma	0.000201	0.00119	CcSEcCtD
Ofloxacin—Dermatitis—Carmustine—malignant glioma	0.000201	0.00119	CcSEcCtD
Ofloxacin—Headache—Carmustine—malignant glioma	0.0002	0.00119	CcSEcCtD
Ofloxacin—Vomiting—Temozolomide—malignant glioma	0.000196	0.00116	CcSEcCtD
Ofloxacin—Rash—Temozolomide—malignant glioma	0.000194	0.00115	CcSEcCtD
Ofloxacin—Dermatitis—Temozolomide—malignant glioma	0.000194	0.00115	CcSEcCtD
Ofloxacin—Headache—Temozolomide—malignant glioma	0.000193	0.00115	CcSEcCtD
Ofloxacin—Nausea—Carmustine—malignant glioma	0.000189	0.00112	CcSEcCtD
Ofloxacin—Nausea—Temozolomide—malignant glioma	0.000183	0.00109	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000114	0.00419	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC5A5—malignant glioma	0.000111	0.00408	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000108	0.00398	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000108	0.00397	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000107	0.00393	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000106	0.00391	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000106	0.00391	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC6A3—malignant glioma	0.000105	0.00389	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NTRK1—malignant glioma	0.000104	0.00382	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	0.000104	0.00382	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	0.000103	0.00381	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—APOD—malignant glioma	0.000103	0.0038	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.0001	0.0037	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.0001	0.00369	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	9.96e-05	0.00367	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	9.87e-05	0.00364	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—COX8A—malignant glioma	9.71e-05	0.00358	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—COX8A—malignant glioma	9.59e-05	0.00354	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	9.55e-05	0.00352	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	9.37e-05	0.00345	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	9.16e-05	0.00338	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	9.09e-05	0.00335	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NCOR1—malignant glioma	9.07e-05	0.00334	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	9.05e-05	0.00333	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—GSTP1—malignant glioma	8.92e-05	0.00329	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—FTH1—malignant glioma	8.88e-05	0.00327	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—FTH1—malignant glioma	8.77e-05	0.00323	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—PLK1—malignant glioma	8.7e-05	0.00321	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	8.62e-05	0.00318	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	8.21e-05	0.00303	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	8.08e-05	0.00298	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	8.01e-05	0.00295	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—RTEL1—malignant glioma	7.82e-05	0.00288	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	7.8e-05	0.00287	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	7.79e-05	0.00287	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—PLK1—malignant glioma	7.78e-05	0.00287	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	7.76e-05	0.00286	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—HIST1H3B—malignant glioma	7.71e-05	0.00284	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	7.67e-05	0.00283	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—APOD—malignant glioma	7.55e-05	0.00278	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	7.52e-05	0.00277	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	7.48e-05	0.00276	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—APOD—malignant glioma	7.46e-05	0.00275	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	7.25e-05	0.00267	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.24e-05	0.00267	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	7.24e-05	0.00267	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	7.21e-05	0.00266	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	7.08e-05	0.00261	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—PDGFB—malignant glioma	7.05e-05	0.0026	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—TFRC—malignant glioma	7.03e-05	0.00259	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	7.01e-05	0.00258	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	6.93e-05	0.00256	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—malignant glioma	6.91e-05	0.00255	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	6.86e-05	0.00253	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—H3F3A—malignant glioma	6.66e-05	0.00245	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PPARG—malignant glioma	6.5e-05	0.0024	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.46e-05	0.00238	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—YWHAE—malignant glioma	6.42e-05	0.00237	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.15e-05	0.00227	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	6.04e-05	0.00223	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	5.96e-05	0.0022	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—H3F3A—malignant glioma	5.96e-05	0.0022	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	5.95e-05	0.00219	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.9e-05	0.00218	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—YWHAE—malignant glioma	5.74e-05	0.00211	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.61e-05	0.00207	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.59e-05	0.00206	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.52e-05	0.00204	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.5e-05	0.00203	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.45e-05	0.00201	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.41e-05	0.00199	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.33e-05	0.00196	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—malignant glioma	5.28e-05	0.00195	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	5.24e-05	0.00193	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	5.17e-05	0.00191	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	5.09e-05	0.00188	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	5.02e-05	0.00185	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.94e-05	0.00182	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.85e-05	0.00179	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	4.82e-05	0.00178	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.64e-05	0.00171	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.62e-05	0.0017	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	4.56e-05	0.00168	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	4.54e-05	0.00167	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	4.52e-05	0.00167	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—COX8A—malignant glioma	4.49e-05	0.00166	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	4.46e-05	0.00164	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	4.37e-05	0.00161	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—BRCA2—malignant glioma	4.35e-05	0.0016	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2B—malignant glioma	4.31e-05	0.00159	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BCAN—malignant glioma	4.29e-05	0.00158	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTT1—malignant glioma	4.24e-05	0.00156	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.19e-05	0.00155	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	4.16e-05	0.00153	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	4.09e-05	0.00151	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	4.07e-05	0.0015	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	4.05e-05	0.00149	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.02e-05	0.00148	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	3.99e-05	0.00147	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—PTGS1—malignant glioma	3.97e-05	0.00146	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—DTX1—malignant glioma	3.88e-05	0.00143	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—malignant glioma	3.86e-05	0.00142	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.86e-05	0.00142	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ASMT—malignant glioma	3.82e-05	0.00141	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—TFRC—malignant glioma	3.82e-05	0.00141	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.77e-05	0.00139	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.73e-05	0.00138	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—BIRC5—malignant glioma	3.72e-05	0.00137	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.66e-05	0.00135	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TERT—malignant glioma	3.6e-05	0.00133	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.59e-05	0.00132	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BCAN—malignant glioma	3.59e-05	0.00132	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.57e-05	0.00131	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.55e-05	0.00131	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.51e-05	0.00129	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.49e-05	0.00129	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	3.44e-05	0.00127	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.38e-05	0.00124	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.34e-05	0.00123	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.28e-05	0.00121	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.17e-05	0.00117	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	3.17e-05	0.00117	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	3.1e-05	0.00114	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	3.1e-05	0.00114	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HEY2—malignant glioma	3.04e-05	0.00112	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—malignant glioma	3.04e-05	0.00112	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IDH1—malignant glioma	2.97e-05	0.0011	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—RTEL1—malignant glioma	2.97e-05	0.00109	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	2.95e-05	0.00109	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	2.95e-05	0.00109	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	2.94e-05	0.00108	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	2.93e-05	0.00108	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	2.9e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—IDH2—malignant glioma	2.9e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HEY1—malignant glioma	2.82e-05	0.00104	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—malignant glioma	2.79e-05	0.00103	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	2.76e-05	0.00102	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIST1H3B—malignant glioma	2.74e-05	0.00101	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.73e-05	0.00101	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2B6—malignant glioma	2.72e-05	0.001	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.68e-05	0.000986	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JAG2—malignant glioma	2.5e-05	0.000921	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—IDH1—malignant glioma	2.49e-05	0.000918	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—malignant glioma	2.47e-05	0.000909	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SPHK1—malignant glioma	2.41e-05	0.000888	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MDM2—malignant glioma	2.39e-05	0.000881	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP2C18—malignant glioma	2.36e-05	0.00087	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.23e-05	0.00082	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.12e-05	0.000782	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—H3F3A—malignant glioma	2.11e-05	0.000779	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	2.09e-05	0.000772	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.05e-05	0.000757	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.03e-05	0.000747	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JAG1—malignant glioma	1.99e-05	0.000735	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.96e-05	0.000721	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FBXW7—malignant glioma	1.95e-05	0.00072	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTT1—malignant glioma	1.91e-05	0.000703	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	1.87e-05	0.000689	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS1—malignant glioma	1.79e-05	0.000659	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.78e-05	0.000657	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—COX8A—malignant glioma	1.71e-05	0.000629	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—MYC—malignant glioma	1.67e-05	0.000616	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BCHE—malignant glioma	1.66e-05	0.000613	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC5A5—malignant glioma	1.64e-05	0.000605	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	1.58e-05	0.000582	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.55e-05	0.000572	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.54e-05	0.000567	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.53e-05	0.000564	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN2B—malignant glioma	1.53e-05	0.000564	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.53e-05	0.000562	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.51e-05	0.000558	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HES1—malignant glioma	1.46e-05	0.000538	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NCOR1—malignant glioma	1.45e-05	0.000535	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ASMT—malignant glioma	1.45e-05	0.000535	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.42e-05	0.000523	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PDGFRA—malignant glioma	1.39e-05	0.000512	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—malignant glioma	1.37e-05	0.000506	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BCAN—malignant glioma	1.36e-05	0.000503	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.34e-05	0.000495	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTP1—malignant glioma	1.32e-05	0.000488	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAT—malignant glioma	1.29e-05	0.000474	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HLA-A—malignant glioma	1.28e-05	0.000472	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TERT—malignant glioma	1.28e-05	0.000472	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PDGFB—malignant glioma	1.25e-05	0.00046	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FGFR1—malignant glioma	1.24e-05	0.000458	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HIF1A—malignant glioma	1.22e-05	0.000451	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NCOR1—malignant glioma	1.22e-05	0.000448	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CAV1—malignant glioma	1.18e-05	0.000436	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BAD—malignant glioma	1.11e-05	0.00041	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOTCH1—malignant glioma	1.1e-05	0.000406	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—IDH2—malignant glioma	1.1e-05	0.000405	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD80—malignant glioma	1.08e-05	0.000398	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APC—malignant glioma	1.08e-05	0.000397	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGF—malignant glioma	1.07e-05	0.000393	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTPN11—malignant glioma	1.06e-05	0.00039	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.04e-05	0.000382	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.03e-05	0.000381	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BRAF—malignant glioma	1.01e-05	0.000373	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAV1—malignant glioma	9.91e-06	0.000365	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT2—malignant glioma	9.86e-06	0.000364	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CD—malignant glioma	9.48e-06	0.000349	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.47e-06	0.000349	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—IDH1—malignant glioma	9.45e-06	0.000348	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SPHK1—malignant glioma	9.15e-06	0.000337	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—FGF2—malignant glioma	9.07e-06	0.000334	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CG—malignant glioma	9.03e-06	0.000333	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP2C18—malignant glioma	8.96e-06	0.00033	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—malignant glioma	8.71e-06	0.000321	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MDM2—malignant glioma	8.49e-06	0.000313	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RAF1—malignant glioma	8.46e-06	0.000312	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.45e-06	0.000312	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ERBB2—malignant glioma	8.37e-06	0.000308	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CB—malignant glioma	8.26e-06	0.000304	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—malignant glioma	8.18e-06	0.000302	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CD—malignant glioma	7.94e-06	0.000292	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.7e-06	0.000284	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.43e-06	0.000274	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTT1—malignant glioma	7.25e-06	0.000267	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTEN—malignant glioma	7.14e-06	0.000263	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CB—malignant glioma	6.92e-06	0.000255	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—malignant glioma	6.85e-06	0.000253	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS1—malignant glioma	6.79e-06	0.00025	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.77e-06	0.000249	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—malignant glioma	6.38e-06	0.000235	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BCHE—malignant glioma	6.32e-06	0.000233	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC5A5—malignant glioma	6.24e-06	0.00023	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTEN—malignant glioma	5.98e-06	0.00022	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MYC—malignant glioma	5.93e-06	0.000219	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.9e-06	0.000217	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.85e-06	0.000215	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—EGFR—malignant glioma	5.8e-06	0.000214	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—KRAS—malignant glioma	5.48e-06	0.000202	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.1e-06	0.000188	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PIK3CA—malignant glioma	5.04e-06	0.000186	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTP1—malignant glioma	5.02e-06	0.000185	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAT—malignant glioma	4.89e-06	0.00018	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NCOR1—malignant glioma	4.62e-06	0.00017	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PIK3CA—malignant glioma	4.22e-06	0.000155	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—AKT1—malignant glioma	4.11e-06	0.000152	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAV1—malignant glioma	3.76e-06	0.000139	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.6e-06	0.000133	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AKT1—malignant glioma	3.44e-06	0.000127	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.43e-06	0.000126	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—malignant glioma	3.31e-06	0.000122	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.01e-06	0.000111	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.63e-06	9.68e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—malignant glioma	2.6e-06	9.59e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTEN—malignant glioma	2.27e-06	8.37e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.6e-06	5.9e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AKT1—malignant glioma	1.31e-06	4.82e-05	CbGpPWpGaD
